(Q90360944)

English

Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM)

scientific article published on 27 July 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM) (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

based on heuristic

inferred from title

author name string

Parul Thakral

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Ishita Sen

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Vineet Pant

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Santosh Kumar Gupta

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sugandha Dureja

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Jyotsna Kumari

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sunil Kumar

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Pallavi Un

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Vindhya Malasani

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

language of work or name

0 references

publication date

27 July 2018

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

British Journal of Radiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

91

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1091

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

20170172

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of action of radiosensitization of conventional chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation sensitizers and targeted therapies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The LundADose method for planar image activity quantification and absorbed-dose assessment in radionuclide therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lutetium-labelled peptides for therapy of neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetric analyses of kidneys, liver, spleen, pituitary gland, and neuroendocrine tumors of patients treated with 177Lu-DOTATATE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of Radiolabeled Somatostatin Analogs in the Spleen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation exposure of the spleen during (177)Lu-DOTATATE treatment and its correlation with haematological toxicity and spleen volume

1 reference

https://pubmed.ncbi.nlm.nih.gov/30028180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1259/BJR.20170172

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30028180%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q90360944&oldid=1787967153"